poisar

Stock

Health Catalyst, Inc HCAT

$2.08+2.72%

Overview

HCAT market data

Price History

HCAT price chart

Valuation & Profitability

no valuation data
No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for HCAT. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

6 captured
Canaccord Genuity Maintains Buy on Health Catalyst, Raises Price Target to $3Benzinga · Jul 21, 2026, 11:28 AM
Wells Fargo Maintains Equal-Weight on Health Catalyst, Raises Price Target to $1.75Benzinga · Jun 26, 2026, 7:10 PM
Health Catalyst Agrees To Divest Vitalware And Vitalware Business Unit To Med-Metrix For Total Consideration Of $147M In CashBenzinga · Jun 4, 2026, 1:15 PM
8-K filing — Health Catalyst, Inc. (HCAT)SEC EDGAR · Jun 4, 2026, 1:10 PM
Cantor Fitzgerald Suspends Health CatalystBenzinga · May 11, 2026, 1:23 PM
Earnings Scheduled For May 11, 2026Benzinga · May 11, 2026, 11:11 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock